ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00299780
Recruitment Status : Completed
First Posted : March 7, 2006
Last Update Posted : April 24, 2007
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Information provided by:
Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : April 2007